At this year’s second annual Pro Bono Awards, Davis Polk recognized eight associates for their commitment to and performance of high-quality pro bono work through charitable donations to be made in their honor. We are pleased to present this year’s honorees and acknowledge their outstanding pro bono achievements. First Place: Kevin Osowski – Kevin has […]
Davis Polk is advising China Biologic Products Holdings, Inc. (“CBPO”) in connection with its acquisition of 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd. from PW Medtech Group Limited, a company listed on the Hong Kong Stock Exchange. As consideration for the acquisition, CBPO will issue new ordinary shares to PWM with a […]
LawFuel.com – Davis Polk advised Equinix, Inc. on its SEC-registered offering of $500 million aggregate principal amount of its 4.875% senior notes due 2020 and $1 billion aggregate principal amount of its 5.375% senior notes due 2023. J.P. Morgan Securities LLC, Barclays Capital Inc., Citigroup Global Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated […]
LawFuel.com – Asia Law News – Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated and SEB Enskilda Inc. as underwriters in connection with an SEC-registered Schedule B debt offering by KEXIM of $500 million aggregate principal amount of its 1.75% notes due 2018. This is the debut “green bonds” offering by an […]